Eli Lilly Overview
- Founded
- 1876

- Status
- Public
- Employees
- 33,625

- Stock Symbol
- LLY

- Investments
- 92
- Share Price
- $202.35
- (As of Thursday Closing)
Eli Lilly General Information
Description
Eli Lilly is a drug company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Contact Information
- Lilly Corporate Center
- Indianapolis, IN 46285
- United States
Eli Lilly Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$202.35 | $201.26 | $117.06 - $204.72 | $194B | 957M | 4.55M | $6.15 |
Eli Lilly Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 155,696,144 | 140,327,287 | 127,299,871 | 99,590,359 |
Revenue | 23,213,800 | 22,319,500 | 21,493,300 | 19,973,800 |
EBITDA | 8,046,900 | 6,818,700 | 5,372,300 | 3,930,700 |
Net Income | 5,572,600 | 8,318,400 | 3,232,000 | (204,100) |
Total Assets | 43,946,000 | 39,286,100 | 43,908,400 | 44,981,000 |
Total Debt | 16,922,100 | 15,803,900 | 10,298,600 | 13,647,100 |
Eli Lilly Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Eli Lilly‘s full profile, request access.
Request a free trialEli Lilly Comparisons
Industry
000000 0
000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialEli Lilly Competitors (11)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Gilead Sciences | Formerly VC-backed | Foster City, CA | 00000 | 00.000 | 000000&0 | |
000000 | Formerly VC-backed | Cambridge, MA | 0000 | 000.00 | 00000000000 | 000.00 |
00000 & 00. | Corporation | Kenilworth, NJ | 00000 | 00000000 | ||
000000 | Formerly VC-backed | North Chicago, IL | 00000 | 00000000000 | ||
00000000000 000000 | Private Equity-Backed | Mexico City, Mexico | 000.00 | 0000000 0000 |
Eli Lilly Executive Team (71)
Eli Lilly Board Members (15)
Name | Representing | Role | Since |
---|---|---|---|
00000 00000 | Eli Lilly | Chief Executive Officer and Chairman of the Board | 000 0000 |
00000 000000 | Self | Chairman, Directors and Corporate Governance Committee | 000 0000 |
000000000 0000000000 00 | Self | Board Member | 000 0000 |
0. 0000000 | Self | Board Member | 000 0000 |
0000000 000 | Self | Board Member | 000 0000 |
Eli Lilly Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialEli Lilly Investments & Acquisitions (92)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000000 0000000 | 08-Jan-2021 | 0000 00000 | Drug Discovery | ||
00000 000000000000 | 05-Jan-2021 | 00000 00000 00 | 0000 | Drug Discovery | |
0000000 0000000000 | 15-Dec-2020 | 000000000000000000 | 00.000 | Biotechnology | 0000 000000 |
0000 000000000 | 10-Dec-2020 | 00000 00000 00 | 0000 | Other Healthcare Services | |
Protomer Technologies | 30-Nov-2020 | Seed Round | 00.00 | Drug Delivery | 0000 000000 00.0 |
Eli Lilly Subsidiaries (8)
Company Name | Industry | Location | Founded |
---|---|---|---|
Loxo Oncology | Acquirer | Stamford, CT | 2013 |
0000 00000000000 | Biotechnology | Redwood City, CA | 0000 |
0000000 000000000 | Biotechnology | Montreal, Canada | 0000 |
0000000 | Pharmaceuticals | Menlo Park, CA | 0000 |
00000 0000 0000000 | Venture Capital | Shanghai, China | 0000 |
Eli Lilly Exits (28)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000000000 | 27-May-2020 | 00000 00000 00 | 00000 | Completed |
|
00000000 | 13-Nov-2018 | 00000 00000 00 | 0000 | Completed |
|
0000000 | 25-Jul-2018 | 00000 00000 00 | 00000 | Completed |
|
0000000 | 19-Dec-2017 | 000000000 | 000 | Completed |
|
Leap Therapeutics | 15-Nov-2017 | PIPE | 0000 | Completed |